Summary & Overview
CPT 0531T: Intracardiac Ischemia Monitor Lead Withdrawal Under Imaging Guidance
CPT code 0531T represents the image-guided withdrawal of the electrode (lead) component of an intracardiac ischemia monitoring system, with imaging supervision and interpretation bundled into the code. This procedure is relevant nationally as intracardiac monitoring devices are used to assess ischemia and cardiac rhythm abnormalities, and safe removal of electrode components requires imaging support and specialized clinical teams. Payers commonly involved in coverage and claims for this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise explanation of the clinical procedure and typical care settings, plus coverage and billing considerations across major national payers. The publication outlines common modifiers used with this service line, identifies typical sites of service, and highlights billing nuances tied to imaging supervision and interpretation being included in the code descriptor. It also provides context on what benchmarks and policy updates readers can expect to see for this procedure and where to look for payer-specific coverage rules. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 0531T describes the withdrawal of the electrode (lead) component of an intracardiac ischemia monitoring system performed under imaging guidance. The code includes all imaging supervision and interpretation associated with the procedure.
Service Type: Device component removal under image guidance
Typical Site of Service: Ambulatory surgical center or hospital outpatient department, where image-guided intracardiac procedures and device component removals are commonly performed.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with a history of coronary artery disease and intermittent exertional chest pain previously had an implantable intracardiac ischemia monitoring system placed to detect transient ischemic episodes. After a predefined monitoring interval or due to device-related symptoms (lead malfunction, infection, or patient discomfort), the treating cardiologist schedules a planned removal of the electrode (lead) component under fluoroscopic imaging guidance. The procedure is performed in an outpatient cardiac catheterization laboratory or interventional radiology suite with sterile technique. Pre-procedure workflow includes review of prior device imaging, anticoagulation management, informed consent, and device interrogation. Intra-procedurally, the operator uses real-time imaging to visualize the lead, withdraws the electrode component, verifies hemostasis and absence of retained fragments, and documents imaging supervision and interpretation. Post-procedure care includes short observation for vascular or cardiac complications, wound care instructions, device log updates, and follow-up scheduling.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typical (e.g., unexpected adhesions or complex lead extraction). |
23 |